Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priority Income Fund G Pref | PRIF-G | Nov 13, 2024 | 24.44 | 0.00 |
Priority Income Fund I Pref | PRIF-I | Nov 13, 2024 | 23.42 | -2.98 |
Priority Income Fund J Pref | PRIF-J | Nov 13, 2024 | 23.29 | +0.26 |
Priority Income Fund Pref | PRIF-H | Nov 13, 2024 | 24.29 | +1.72 |
Priority Technology | PRTH | Nov 13, 2024 | 8.43 | -1.40 |
Privia Health Group | PRVA | Nov 13, 2024 | 21.84 | -3.28 |
Pro-Dex | PDEX | Nov 13, 2024 | 46.96 | -5.23 |
ProAssurance | PRA | Nov 13, 2024 | 17.17 | +0.41 |
Procaps Group | PROC | Nov 13, 2024 | 0.85 | -12.37 |
Procept BioRobotics | PRCT | Nov 13, 2024 | 92.25 | -3.45 |
Processa Pharmaceuticals | PCSA | Nov 13, 2024 | 1.07 | 0.00 |
Procore Technologies | PCOR | Nov 13, 2024 | 73.42 | +3.42 |
Procter & Gamble | PG | Nov 13, 2024 | 166.58 | +0.45 |
Professional Diversity Network | IPDN | Nov 13, 2024 | 0.70 | -2.76 |
Proficient Auto Logistics | PAL | Nov 13, 2024 | 9.42 | +1.84 |
Profire Energy | PFIE | Nov 13, 2024 | 2.52 | 0.00 |
Profound Medical | PROF | Nov 13, 2024 | 8.17 | +2.64 |
ProFrac A | ACDC | Nov 13, 2024 | 7.01 | -3.18 |
PROG | PRG | Nov 13, 2024 | 48.84 | +1.24 |
Progress Software | PRGS | Nov 13, 2024 | 68.06 | -0.69 |
Progressive | PGR | Nov 13, 2024 | 261.37 | -0.37 |
Progyny | PGNY | Nov 13, 2024 | 13.90 | -19.09 |
ProKidney | PROK | Nov 13, 2024 | 2.07 | +0.98 |
Prologis | PLD | Nov 13, 2024 | 116.57 | +3.39 |
ProMIS Neurosciences | PMN | Nov 13, 2024 | 0.98 | 0.00 |
PropertyGuru | PGRU | Nov 13, 2024 | 6.63 | -0.15 |
ProPetro | PUMP | Nov 13, 2024 | 7.86 | -2.12 |
ProPhase Labs | PRPH | Nov 13, 2024 | 0.77 | +4.39 |
ProQR Therapeutics | PRQR | Nov 13, 2024 | 3.96 | -0.50 |
PROS | PRO | Nov 13, 2024 | 23.33 | +1.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.